Guidance on the implementation of decentralised elements in clinical trials with medicinal products is now available: Decentralised clinical trials with medicinal products meet the patients, wherever they are, in a faster and more efficient process benefitting both patient, healthcare professionals and industry. It is therefore gratifying to be able to announce that another important milestone […]Continue reading

error: Content is protected !!